Good Times Restaurants Inc.
GTIMGood Times Restaurants Inc. (GTIM) is a fast-food chain specializing in burgers, sandwiches, and other American casual dining offerings. Founded in 1987 and based in Lafayette, Colorado, the company operates several locations primarily in the western United States, focusing on delivering quality food with a fun, retro-themed atmosphere. Good Times emphasizes fresh ingredients and customizable menu options to appeal to a broad customer base.
Company News
Good Times Restaurants reported Q2 2026 results with total revenues of $33.2 million (down 3.1% YoY) due to restaurant closures and reduced traffic, partially offset by menu price increases. Both Bad Daddy's and Good Times segments showed sequential same-store sales improvement. The company achieved profitability with net income of $0.1 million (...
Good Times Restaurants reported challenging Q1 2026 results with total revenues down 5.1% to $34 million and adjusted EBITDA turning negative at -$74,000. Both the Good Times and Bad Daddy's burger concepts faced headwinds from soft customer traffic, record-high ground beef costs, and labor cost inflation. However, management noted sequential imp...
The Dow Jones dipped around 575 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transactions...
The Dow Jones closed lower by over 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision. Below is a look at a few recent notable insider transa...
Gainers Prothena Corporation plc (NASDAQ: PRTA) shares climbed 76.4% to $54.54 after Biogen and Eisai Co. Ltd. announced late Tuesday positive results from a late-stage study of their Alzheimer’s treatment candidate. Prothena is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with t...
